<!DOCTYPE html>
<html class="">
<head>
<meta charset="utf-8">
<title>Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding | Bain Capital</title>

<meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1">
<meta name="robots" content="index, follow">
<meta name="keywords" content="Bain Capital">
<meta name="description" content="Bain Capital, LP is one of the world’s leading multi-asset alternative investment firms. With offices on four continents, our global team aligns our interests with those of our investors and partners for lasting impact.">
<meta name="author" content="Bain Capital">
<meta name="google-site-verification" content="ODlIezZbgft2XTHEQrorp22WcvsQF2eq3Phq47ytg88">
<link rel="canonical" href="../index.htm">

<meta property="og:title" content="Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding">
<meta property="og:image" content="https://www.baincapital.com/sites/default/files/news/Areteia_0.png">
<meta property="og:description" content="Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding">
<meta property="og:url" content="https://www.baincapital.com/news/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage">
<meta property="og:site_name" content="Bain Capital">
<meta property="og:type" content="website">
<meta name="twitter:card" content="summary">
<meta property="og:image:width" content="1200">
<meta property="og:image:height" content="627">


<style type="text/css" media="all">
@import url("../sites/all/modules/media/modules/media_wysiwyg/css/media_wysiwyg.base-1.css");
</style>
<style type="text/css" media="all">
@import url("../sites/all/modules/eu_cookie_compliance/css/eu_cookie_compliance-1.css");
@import url("../sites/default/files/ctools/css/8695a9d3e23511e74e4cde79b7ae1666-1.css");
</style>
<style type="text/css" media="all">
@import url("../sites/all/themes/baincapital/assets/css/bootstrap.min-1.css");
@import url("../sites/all/themes/baincapital/assets/css/animate-1.css");
</style>
<link rel="stylesheet" type="text/css" href="../sites/all/themes/baincapital/assets/css/web37-1.css">
<link rel="stylesheet" type="text/css" href="../sites/all/themes/baincapital/assets/css/private-equity22-1.css">
<link rel="stylesheet" type="text/css" href="../sites/all/themes/baincapital/assets/css/citizen-1.css">

<link rel="apple-touch-icon" sizes="144x144" href="../sites/all/themes/baincapital/assets/ico/apple-touch-icon-144-precomposed-1.png">
<link rel="shortcut icon" href="../sites/all/themes/baincapital/assets/ico/favicon-1.png">
<link id="page_favicon" href="../sites/all/themes/baincapital/assets/ico/favicon-1.ico" rel="icon" type="image/x-icon">

<script type="text/javascript" src="../sites/all/modules/jquery_update/replace/jquery/1.12/jquery.min-1.js?v=1.12.4"></script>
<script type="text/javascript" src="../misc/jquery-extend-3.4.0-1.js?v=1.12.4"></script>
<script type="text/javascript" src="../misc/jquery-html-prefilter-3.5.0-backport-1.js?v=1.12.4"></script>
<script type="text/javascript" src="../sites/all/modules/jquery_update/js/jquery_browser-1.js?v=0.0.1"></script>
<script type="text/javascript" src="../sites/all/modules/eu_cookie_compliance/js/jquery.cookie-1.4.1.min-1.js?v=1.4.1"></script>
<script type="text/javascript" src="../sites/all/modules/themekey/themekey_redirect/themekey_redirect-1.js?sghuir"></script>
<script type="text/javascript" src="../misc/drupal-1.js?sghuir"></script>
<script type="text/javascript" src="../misc/jquery.once-1.js?sghuir"></script>
<script type="text/javascript" src="../sites/all/themes/baincapital/assets/js/modernizr-custom-1.js?sghuir"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings, {"basePath":"\/","pathPrefix":"","setHasJsCookie":0,"ajaxPageState":{"theme":"baincapital","theme_token":"PIf32Od1zvOjz95pwKqWp974pSYcN1s9Bk7m9j96NmM","js":{"0":1,"sites\/all\/modules\/eu_cookie_compliance\/js\/eu_cookie_compliance.min.js":1,"sites\/all\/themes\/baincapital\/assets\/js\/all-jquery.js":1,"sites\/all\/themes\/baincapital\/assets\/js\/bootstrap.min.js":1,"sites\/all\/themes\/baincapital\/assets\/js\/owl.carousel.js":1,"sites\/all\/themes\/baincapital\/assets\/js\/tweet.js":1,"sites\/all\/themes\/baincapital\/assets\/js\/jquery.waypoints.min.js":1,"sites\/all\/themes\/baincapital\/assets\/js\/scrollfix.js":1,"sites\/all\/themes\/baincapital\/assets\/js\/news_detail.js":1,"sites\/all\/themes\/baincapital\/assets\/js\/mainjq.js":1,"sites\/all\/themes\/baincapital\/assets\/js\/bc-private-equity.js":1,"sites\/all\/modules\/jquery_update\/replace\/jquery\/1.12\/jquery.min.js":1,"misc\/jquery-extend-3.4.0.js":1,"misc\/jquery-html-prefilter-3.5.0-backport.js":1,"sites\/all\/modules\/jquery_update\/js\/jquery_browser.js":1,"sites\/all\/modules\/eu_cookie_compliance\/js\/jquery.cookie-1.4.1.min.js":1,"sites\/all\/modules\/themekey\/themekey_redirect\/themekey_redirect.js":1,"\/misc\/drupal.js":1,"\/misc\/jquery.once.js":1,"sites\/all\/themes\/baincapital\/assets\/js\/modernizr-custom.js":1},"css":{"sites\/all\/modules\/media\/modules\/media_wysiwyg\/css\/media_wysiwyg.base.css":1,"sites\/all\/modules\/eu_cookie_compliance\/css\/eu_cookie_compliance.css":1,"public:\/\/ctools\/css\/8695a9d3e23511e74e4cde79b7ae1666.css":1,"sites\/all\/themes\/baincapital\/assets\/css\/bootstrap.min.css":1,"sites\/all\/themes\/baincapital\/assets\/css\/animate.css":1}},"ThemeKeyRedirect":{"checkOnce":false,"redirectOnce":false},"eu_cookie_compliance":{"cookie_policy_version":"1.0.0","popup_enabled":1,"popup_agreed_enabled":0,"popup_hide_agreed":0,"popup_clicking_confirmation":false,"popup_scrolling_confirmation":false,"popup_html_info":"\u003Cdiv class=\u0022eu-cookie-compliance-banner eu-cookie-compliance-banner-info eu-cookie-compliance-banner--categories\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n        \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003E\u003Cstrong\u003EThis site uses cookies.\u003C\/strong\u003E To see how cookies are used, please review our \u003Ca href=\u0022https:\/\/www.baincapital.com\/privacy-policy\u0022 target=\u0022_blank\u0022\u003Ecookie notice\u003C\/a\u003E. If you agree to our use of cookies, please continue to use our site.\u003C\/p\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003ENo, give me more info\u003C\/button\u003E\n          \u003C\/div\u003E\n          \u003Cdiv id=\u0022eu-cookie-compliance-categories\u0022 class=\u0022eu-cookie-compliance-categories\u0022\u003E\n                  \u003Cdiv class=\u0022eu-cookie-compliance-category\u0022\u003E\n            \u003Cdiv\u003E\n              \u003Cinput type=\u0022checkbox\u0022 name=\u0022cookie-categories\u0022 id=\u0022cookie-category-necessary\u0022\n                     value=\u0022necessary\u0022\n                     checked                     disabled \u003E\n              \u003Clabel for=\u0022cookie-category-necessary\u0022\u003ENecessary\u003C\/label\u003E\n            \u003C\/div\u003E\n                      \u003Cdiv class=\u0022eu-cookie-compliance-category-description\u0022\u003E\u003C\/div\u003E\n                  \u003C\/div\u003E\n                  \u003Cdiv class=\u0022eu-cookie-compliance-category\u0022\u003E\n            \u003Cdiv\u003E\n              \u003Cinput type=\u0022checkbox\u0022 name=\u0022cookie-categories\u0022 id=\u0022cookie-category-functional\u0022\n                     value=\u0022functional\u0022\n                     checked                      \u003E\n              \u003Clabel for=\u0022cookie-category-functional\u0022\u003EFunctional\u003C\/label\u003E\n            \u003C\/div\u003E\n                      \u003Cdiv class=\u0022eu-cookie-compliance-category-description\u0022\u003E\u003C\/div\u003E\n                  \u003C\/div\u003E\n                  \u003Cdiv class=\u0022eu-cookie-compliance-category\u0022\u003E\n            \u003Cdiv\u003E\n              \u003Cinput type=\u0022checkbox\u0022 name=\u0022cookie-categories\u0022 id=\u0022cookie-category-analytics\u0022\n                     value=\u0022analytics\u0022\n                     checked                      \u003E\n              \u003Clabel for=\u0022cookie-category-analytics\u0022\u003EAnalytics\u003C\/label\u003E\n            \u003C\/div\u003E\n                      \u003Cdiv class=\u0022eu-cookie-compliance-category-description\u0022\u003E\u003C\/div\u003E\n                  \u003C\/div\u003E\n                  \u003Cdiv class=\u0022eu-cookie-compliance-category\u0022\u003E\n            \u003Cdiv\u003E\n              \u003Cinput type=\u0022checkbox\u0022 name=\u0022cookie-categories\u0022 id=\u0022cookie-category-performance\u0022\n                     value=\u0022performance\u0022\n                     checked                      \u003E\n              \u003Clabel for=\u0022cookie-category-performance\u0022\u003EPerformance\u003C\/label\u003E\n            \u003C\/div\u003E\n                      \u003Cdiv class=\u0022eu-cookie-compliance-category-description\u0022\u003E\u003C\/div\u003E\n                  \u003C\/div\u003E\n                          \u003Cdiv class=\u0022eu-cookie-compliance-categories-buttons\u0022\u003E\n            \u003Cbutton type=\u0022button\u0022\n                    class=\u0022eu-cookie-compliance-save-preferences-button\u0022\u003ESave preferences\u003C\/button\u003E\n          \u003C\/div\u003E\n              \u003C\/div\u003E\n    \n    \u003Cdiv id=\u0022popup-buttons\u0022 class=\u0022eu-cookie-compliance-has-categories\u0022\u003E\n            \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button eu-cookie-compliance-hidden\u0022 \u003EWithdraw consent\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","use_mobile_message":false,"mobile_popup_html_info":"\u003Cdiv class=\u0022eu-cookie-compliance-banner eu-cookie-compliance-banner-info eu-cookie-compliance-banner--categories\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n        \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Ch2\u003EWe use cookies on this site to enhance your user experience\u003C\/h2\u003E\n\u003Cp\u003EBy tapping the Accept button, you agree to us doing so.\u003C\/p\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003ENo, give me more info\u003C\/button\u003E\n          \u003C\/div\u003E\n          \u003Cdiv id=\u0022eu-cookie-compliance-categories\u0022 class=\u0022eu-cookie-compliance-categories\u0022\u003E\n                  \u003Cdiv class=\u0022eu-cookie-compliance-category\u0022\u003E\n            \u003Cdiv\u003E\n              \u003Cinput type=\u0022checkbox\u0022 name=\u0022cookie-categories\u0022 id=\u0022cookie-category-necessary\u0022\n                     value=\u0022necessary\u0022\n                     checked                     disabled \u003E\n              \u003Clabel for=\u0022cookie-category-necessary\u0022\u003ENecessary\u003C\/label\u003E\n            \u003C\/div\u003E\n                      \u003Cdiv class=\u0022eu-cookie-compliance-category-description\u0022\u003E\u003C\/div\u003E\n                  \u003C\/div\u003E\n                  \u003Cdiv class=\u0022eu-cookie-compliance-category\u0022\u003E\n            \u003Cdiv\u003E\n              \u003Cinput type=\u0022checkbox\u0022 name=\u0022cookie-categories\u0022 id=\u0022cookie-category-functional\u0022\n                     value=\u0022functional\u0022\n                     checked                      \u003E\n              \u003Clabel for=\u0022cookie-category-functional\u0022\u003EFunctional\u003C\/label\u003E\n            \u003C\/div\u003E\n                      \u003Cdiv class=\u0022eu-cookie-compliance-category-description\u0022\u003E\u003C\/div\u003E\n                  \u003C\/div\u003E\n                  \u003Cdiv class=\u0022eu-cookie-compliance-category\u0022\u003E\n            \u003Cdiv\u003E\n              \u003Cinput type=\u0022checkbox\u0022 name=\u0022cookie-categories\u0022 id=\u0022cookie-category-analytics\u0022\n                     value=\u0022analytics\u0022\n                     checked                      \u003E\n              \u003Clabel for=\u0022cookie-category-analytics\u0022\u003EAnalytics\u003C\/label\u003E\n            \u003C\/div\u003E\n                      \u003Cdiv class=\u0022eu-cookie-compliance-category-description\u0022\u003E\u003C\/div\u003E\n                  \u003C\/div\u003E\n                  \u003Cdiv class=\u0022eu-cookie-compliance-category\u0022\u003E\n            \u003Cdiv\u003E\n              \u003Cinput type=\u0022checkbox\u0022 name=\u0022cookie-categories\u0022 id=\u0022cookie-category-performance\u0022\n                     value=\u0022performance\u0022\n                     checked                      \u003E\n              \u003Clabel for=\u0022cookie-category-performance\u0022\u003EPerformance\u003C\/label\u003E\n            \u003C\/div\u003E\n                      \u003Cdiv class=\u0022eu-cookie-compliance-category-description\u0022\u003E\u003C\/div\u003E\n                  \u003C\/div\u003E\n                          \u003Cdiv class=\u0022eu-cookie-compliance-categories-buttons\u0022\u003E\n            \u003Cbutton type=\u0022button\u0022\n                    class=\u0022eu-cookie-compliance-save-preferences-button\u0022\u003ESave preferences\u003C\/button\u003E\n          \u003C\/div\u003E\n              \u003C\/div\u003E\n    \n    \u003Cdiv id=\u0022popup-buttons\u0022 class=\u0022eu-cookie-compliance-has-categories\u0022\u003E\n            \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button eu-cookie-compliance-hidden\u0022 \u003EWithdraw consent\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","mobile_breakpoint":"768","popup_html_agreed":"\u003Cdiv\u003E\n  \u003Cdiv class=\u0022popup-content agreed\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Ch2\u003EThank you for accepting cookies\u003C\/h2\u003E\u003Cp\u003EYou can now hide this message or find out more about cookies.\u003C\/p\u003E    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022hide-popup-button eu-cookie-compliance-hide-button\u0022\u003EHide\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button-thank-you\u0022 \u003EMore info\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"https:\/\/www.baincapital.com\/privacy-policy","popup_link_new_window":1,"popup_position":null,"fixed_top_position":1,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":0,"reload_page":0,"domain":"","domain_all_sites":0,"popup_eu_only_js":0,"cookie_lifetime":"1","cookie_session":false,"disagree_do_not_show_popup":0,"method":"categories","allowed_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Ch2\u003EWe use cookies on this site to enhance your user experience\u003C\/h2\u003E\u003Cp\u003EYou have given your consent for us to set cookies.\u003C\/p\u003E    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button\u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","withdraw_enabled":false,"withdraw_button_on_info_popup":0,"cookie_categories":["necessary","functional","analytics","performance"],"cookie_categories_details":{"necessary":{"weight":0,"machine_name":"necessary","label":"Necessary","description":"","checkbox_default_state":"required"},"functional":{"weight":0,"machine_name":"functional","label":"Functional","description":"","checkbox_default_state":"checked"},"analytics":{"weight":0,"machine_name":"analytics","label":"Analytics","description":"","checkbox_default_state":"checked"},"performance":{"weight":0,"machine_name":"performance","label":"Performance","description":"","checkbox_default_state":"checked"}},"enable_save_preferences_button":1,"cookie_name":"","cookie_value_disagreed":"0","cookie_value_agreed_show_thank_you":"1","cookie_value_agreed":"2","containing_element":"body","automatic_cookies_removal":1,"close_button_action":"close_banner"},"urlIsAjaxTrusted":{"\/news\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage":true}});
//--><!]]>
</script>
<script>
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
})(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

ga('create', 'UA-102152661-2', 'auto');
ga('send', 'pageview');

</script>

<script async="" src="../gtag/js-1?id=G-6BWYF3TYMK"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'G-6BWYF3TYMK');
</script>

<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-WLFBKSQ4');</script>

<!--[if IE 9]>
<link rel="stylesheet" href="https://www.baincapital.com/sites/all/themes/baincapital/assets/css/ie.css" type="text/css" media="all">
<![endif]-->
<!--[if IE 9]>
<script src="https://cdnjs.cloudflare.com/ajax/libs/classlist/2014.01.31/classList.min.js"></script>
<![endif]-->
<script type="application/ld+json">
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Bain Capital",
"url": "https://www.baincapital.com/",
"logo": "https://www.baincapital.com/sites/all/themes/baincapital/assets/images/bain-capital-logo.png",
 "mainEntityOfPage": {
      "@type": "WebPage",
      "url": ["https://www.reuters.com/article/us-toshiba-accounting/toshiba-to-sell-chip-unit-to-bain-capital-led-group-for-18-billion-idUSKCN1BV0AB","https://www.bloomberg.com/news/articles/2017-09-20/toshiba-agrees-to-sell-memory-chip-unit-to-bain-led-group","https://www.washingtonpost.com/world/asia_pacific/toshiba-board-decides-on-chip-sale-to-bain-capital-group/2017/09/20/78575586-9e04-11e7-b2a7-bc70b6f98089_story.html?utm_term=.75d83e172a7c","https://www.forbes.com/sites/clareoconnor/2014/08/20/bain-deal-makes-toms-shoes-founder-blake-mycoskie-a-300-million-man/#611103ef5668"
      ]
   },
   "sameAs": [
"https://www.linkedin.com/company/bain-capital",
"https://twitter.com/baincapital",
"https://www.youtube.com/channel/UCHLw83UfiBEm9RoLlZKPaig"],
 	"disambiguatingDescription": "Private investment firm",
    "brand": {
	"@type": "Organization",
	"name": "Bain & Co.",
	"disambiguatingDescription": "global management consulting firm"
	}
}
</script><style>
@media (max-width: 4799px) and (min-width: 4101px){
	.slantStraight {
		height: 1420px;
	}
	.slider-content {
		margin-top: -605px;
	}
	.allContent #__ourvaluesWrap {
		margin-top: -360px;
	}
}
@media (max-width: 3549px) and (min-width: 2550px){
	.slider-content {
		margin-top: -390px;
	}
	.slantStraight {
		height: 1120px;
	}
	.allContent #__ourvaluesWrap {
		margin-top: -200px;
	}
}
</style>
</head>
<body class="not-front 
	community_partner community_partnerDetail newsrommdetailDH newsRoomWrapDt
		">
<img src="../fe32073b-1" style="position: absolute" referrerpolicy="no-referrer-when-downgrade">
<script type="text/javascript" src="../js/300/addthis_widget-1.js#pubid=ra-4e6d17642aada598"></script>

<header id="__header" data-scroll-header="" data-gumshoe-header="">

<div class="collapse investorLoginWrap search-bar" id="searchOpen">
<div class="container-fluid">
<div class="row">
<div class="col-md-12">
<div class="main-container">
<form class="SearchFrm" action="https://www.baincapital.com/search/node/" method="GET" autocomplete="off" onsubmit="return validateForm('desktop');">
<input class="sb-search-input" placeholder="Search..." type="text" value="" name="keys" id="keys">
<input type="hidden" name="build_id" value="form-1qS3LAyubkdBRMr6CydHzp3o6aiv-pGrDXmvu_dTCxA">
<input class="" type="submit" value="&nbsp;" name="op">
</form>
<script type="text/javascript">
								function validateForm(view)
								{	
									if(view=='desktop' && $('input[type="text"]').val().trim().length == 0)	
									{
										focusonelement();
										return false;
									}
									
									if(view=='mobile' && $('.mobileSearch input[type="text"]').val().trim().length == 0)
									{
										focusonelement();
										return false;
									}
								}
								</script>
</div>
</div>
</div>
</div>
</div>
<div class="topLinks hidden-sm hidden-xs">
<div class="container-fluid">
<div class="row posR">
<nav class="text-right">
<a class="text-uppercase hvr-sweep-to-top  topinvestor  __inr-btn " href="https://services.sungarddx.com/Document/2449254" target="_blank" rel="nofollow noopener noreferrer">Investor Login</a>
<a class="text-uppercase hvr-sweep-to-top  " href="../locations.html">Locations</a>
<div class="topBainCapitalInfo pull-left">
<a href="#moreLinksFooter" class="moreDetailHeader moreMenuHeader" data-toggle="collapse">More <span class="caret"></span></a> </div>
</nav>
<div id="searchContainer" class="sb-search search-ico">
<a class="sb-icon-search" id="search-button" data-toggle="collapse" href="#searchOpen" onclick="focusonelement();">SEARCH</a>
</div>
</div>
</div>
</div>

<div class="collapse moreLinksFooterWrap" id="moreLinksFooter">
<div class="container-fluid">
<div class="row">
<div class="col-lg-7 col-md-12 col-sm-12 col-xs-12 footerPadd0">
<div class="row">
<section class="header-section-left col-md-15 col-sm-15">
<h3><a href="../about-us.html" target="" rel="noopener noreferrer">About Us</a></h3>
<ul>
<li>
<a href="../about-us.html#aboutBC">About Bain Capital</a>
</li>
<li>
<a href="../about-us.html#ourValues">Our Values</a>
</li>
<li>
<a href="../about-us.html#timeline">Our History</a>
</li>
<li>
<a href="../about-us.html#countNumber">By the Numbers</a>
</li>
</ul>
<h3 class="localwebsite_heading"><a href="javascript:void(0);">Local Sites</a></h3>
<ul class="localwebsite_menulist">
<li>
<a href="https://www.baincapital.co.jp/">Japan - 日本</a>
</li>
</ul>
</section>
<section class="header-section-left col-md-15 col-sm-15">
<h3><a href="../businesses.html">Businesses</a></h3>
<ul>
<li>
<a href="https://baincapitalprivateequity.com/" target="_blank" rel="noopener noreferrer">Private Equity</a>
</li>
<li>
<a href="https://www.baincapitalcredit.com/" target="_blank" rel="noopener noreferrer">Credit</a>
</li>
<li>
<a href="//baincapitalspecialsituations.com/">Special Situations</a>
</li>
<li>
<a href="../businesses/ventures/index.htm" target="_blank" rel="noopener noreferrer">Venture</a>
</li>
<li>
<a href="https://www.baincapitalrealestate.com" target="" rel="noopener noreferrer">Real Estate</a>
</li>
<li>
<a href="//baincapitaltechopportunities.com" target="_blank" rel="noopener noreferrer">Tech Opportunities</a>
</li>
<li>
<a href="https://www.baincapitallifesciences.com" target="" rel="noopener noreferrer">Life Sciences</a>
</li>
<li>
<a href="https://www.baincapitalpublicequity.com/" target="_blank" rel="noopener noreferrer">Public Equity</a>
</li>
<li>
<a href="//www.baincapitalpartnershipstrategies.com" target="_blank" rel="noopener noreferrer">Partnership Strategies</a>
</li>
<li>
<a href="https://www.baincapitalinsurance.com/" target="_blank" rel="noopener noreferrer">Insurance</a>
</li>
<li>
<a href="https://baincapitaldoubleimpact.com/" target="_blank" rel="noopener noreferrer">Double Impact</a>
</li>
<li>
<a href="../businesses/crypto.html" target="_blank" rel="noopener noreferrer">Crypto</a>
</li>
</ul>
</section>
<section class="header-section-left col-md-15 col-sm-15">
<h3><a href="../people-19.html">People</a></h3>
<ul>
<li>
<a href="../people-19.html">Businesses</a>
</li>
<li>
<a href="../people-20.html?dept=38">Corporate</a>
</li>
</ul>
</section>
<section class="header-section-left col-md-15 col-sm-15">
<h3><a href="../esgandimpact/index.htm">ESG & Impact</a></h3>
<ul>
</ul>
</section>
<section class="header-section-left col-md-15 col-sm-15">
<h3><a href="../news.html">Newsroom</a></h3>
</section>
</div>
</div>
<div class="col-xs-12  col-sm-12 col-md-12 col-lg-5 fullPara">
<p><strong>Bain Capital, LP</strong> is one of the world’s leading private investment firms with approximately $185 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact. </p>
</div>
</div>
</div>
</div>


<div class="collapse investorLoginWrap" id="investorLogin">
<div class="container-fluid">
<div class="row">
<div class="col-md-7">
<div class="col-md-6">
<p><strong class="paddB5">Bain Capital Investor Portal</strong> Please log in to access your account information. If you have any questions regarding your account, please contact <a href="mailto:ir@baincapital.com">ir@baincapital.com</a>.</p>
</div>
<div class="col-md-6">
<div class="signinOption">
<h4>Sign on to your account</h4>
<div class="btn-group">
<button type="button" class="btn btn-default dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
Select an account <span class="caret"></span>
</button>
<ul class="dropdown-menu">
<li><a href="https://services.intralinks.com/branding/4136419019/?clientID=4136419019" target="_blank" rel="nofollow noopener noreferrer">Private Equity</a></li>
<li><a href="https://services.intralinks.com/branding/3096257632/?clientID=3096257632" target="_blank" rel="nofollow noopener noreferrer">Credit</a></li>
<li><a href="https://services.intralinks.com/branding/4032613659/?clientID=4032613659" target="_blank" rel="nofollow noopener noreferrer">Public Equity</a></li>
<li><a href="https://services.intralinks.com/branding/8925604850/?clientID=8925604850" target="_blank" rel="nofollow noopener noreferrer">Ventures</a></li>
<li><a href="https://services.intralinks.com/branding/6382588619/?clientID=6382588619" target="_blank" rel="nofollow noopener noreferrer">Real Estate</a></li>
<li><a href="https://services.intralinks.com/branding/2968698844/?clientID=2968698844" target="_blank" rel="nofollow noopener noreferrer">Double Impact</a></li>
<li><a href="https://services.intralinks.com/branding/7947916997/?clientID=7947916997" target="_blank" rel="nofollow noopener noreferrer">Life Sciences</a></li>
<li><a href="https://services.intralinks.com/branding/9037940544/?clientID=9037940544" target="_blank" rel="nofollow noopener noreferrer">Partnership Strategies</a></li>
</ul>
</div>
</div>
</div>
</div>
<div class="col-md-5">
<div class="col-md-6">


<strong>Questions?</strong><br>
Call Us: <a href="https://intralinks.custhelp.com/app/answers/detail_clear/a_id/4034" target="_blank" rel="nofollow noopener noreferrer">24 x 7 Global Phone Support</a><br>
Email Us: <a href="mailto:support@intralinks.com">support@intralinks.com</a><br>

<a style="display: block; margin-top: 1em;" href="https://baincapital.com/people?dept=39">Meet the Bain Capital Investor Relations team</a>
</div>
</div> </div>
</div> </div>

<div class="logoTop  animated ">

<div class="container-fluid">
<div class="__logo-container">
<nav class="navbar navbar-default">
<div class="container-fluid">

<div class="row">
<div class="col-xs-12 col-sm-3 col-md-3 navHeaderMob">

<div class="navbar-header">
<a class="navbar-brand animated fadeIn " href="../index.htm" title="Bain Capital">
<img src="../sites/all/themes/baincapital/assets/images/bain-capital-logo-1.svg" alt="Bain Capital">
</a>
<input id="op" type="checkbox">
<div class="lower visible-xs visible-sm">
<label for="op"><img onclick="focusonelement();" src="../sites/all/themes/baincapital/assets/images/menu-mobile-1.png" alt="Click to Open"></label>
</div>
<div class="overlay overlay-hugeinc hidden-md hidden-lg animated fadeInDown">
<div class="container-fluid">
<div class="blueMobileSlant">
<div class="">
<nav>
<div class="row">
<div class="col-xs-7 col-sm-7">
<a class="menuLogo" href="../index.htm"><img src="../sites/all/themes/baincapital/assets/images/menu-logo4-1.png" alt="Bain Capital"></a>
</div>
<div class="col-xs-5 col-sm-5">
<label for="op"></label>
</div>
</div>
<div class="row">
<div class="col-xs-12">
<ul>
<li class="">
<a href="../about-us.html">About Us
</a>
</li>
<li class="">
<a class="openSubMenu" href="../businesses.html">Businesses
<span class="menuIconsPlus collapsed" data-toggle="collapse" data-target="#submenuBusinesses"></span>
</a>
<ul class="submenuCitizen collapse" id="submenuBusinesses">
<li><a target="_blank" href="//baincapitalprivateequity.com/" rel="noopener noreferrer">Private Equity</a></li>
<li><a target="_blank" href="//www.baincapitalcredit.com/" rel="noopener noreferrer">Credit</a></li>
<li><a href="//baincapitalspecialsituations.com/">Special Situations</a></li>
<li><a target="_blank" href="../businesses/ventures/index.htm" rel="noopener noreferrer">Venture</a></li>
<li><a target="" href="https://www.baincapitalrealestate.com" rel="noopener noreferrer">Real Estate</a></li>
<li><a target="_blank" href="//www.baincapitaltechopportunities.com" rel="noopener noreferrer">Tech Opportunities</a></li>
<li><a target="" href="https://www.baincapitallifesciences.com" rel="noopener noreferrer">Life Sciences</a></li>
<li><a target="_blank" href="//baincapitalpublicequity.com/" rel="noopener noreferrer">Public Equity</a></li>
<li><a target="_blank" href="//www.baincapitalpartnershipstrategies.com" rel="noopener noreferrer">Partnership Strategies</a></li>
<li><a target="_blank" href="https://www.baincapitalinsurance.com/" rel="noopener noreferrer">Insurance</a></li>
<li><a target="_blank" href="//baincapitaldoubleimpact.com" rel="noopener noreferrer">Double Impact</a></li>
<li><a target="_blank" href="../businesses/crypto.html" rel="noopener noreferrer">Crypto</a></li>
</ul>
</li>
<li class="">
<a href="../people-19.html">People
</a>
</li>
<li class="">
<a href="///www.baincapital.com/esgandimpact/">ESG & Impact
</a>
</li>
<li class="active ">
<a href="../news.html">Newsroom
</a>
</li>
</ul>
</div>
<div class="col-xs-12">
<a class="investorMobile" href="https://services.sungarddx.com/Document/2449254" target="_blank" rel="nofollow noopener noreferrer">Investor Login</a>
<a class="investorMobile" href="../locations.html">Locations</a>
<a class="investorMobile" href="javascript:void(0);" data-toggle="modal" data-target="#moreLinksFooterModal">More</a>
<form class="mobileSearch" action="https://www.baincapital.com/search/node/" method="GET" autocomplete="off" onsubmit="return validateForm('mobile');">
<input type="submit" class="" value="&nbsp;">
<div class="form-group">
<input type="text" class="form-control" placeholder="Search" name="keys" id="mobile_keys" autofocus="" value="">
<input type="hidden" name="build_id" value="form-1qS3LAyubkdBRMr6CydHzp3o6aiv-pGrDXmvu_dTCxA">
</div>
</form>
</div>
</div>
</nav>
</div>
<img class="mobile-slantImg" src="../sites/all/themes/baincapital/assets/images/grey-mobile-slant3-1.png" alt="Bain Capital">
</div>
</div>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-9 col-md-9">

<div class="collapse navbar-collapse animated fadeIn hidden-xs hidden-sm" id="navigation">
<ul class="pull-right nav navbar-nav overlay-menu">
<li><a class="hvr-underline-from-center " href="../about-us.html">
About Us </a>
</li>
<li><a class="hvr-underline-from-center " href="../businesses.html">
Businesses </a>
<ul class="submenuCitizen submenuBc">
<li><a target="_blank" href="//baincapitalprivateequity.com/" rel="noopener noreferrer">Private Equity</a></li>
<li><a target="_blank" href="//www.baincapitalcredit.com/" rel="noopener noreferrer">Credit</a></li>
<li><a href="//baincapitalspecialsituations.com/">Special Situations</a></li>
<li><a target="_blank" href="../businesses/ventures/index.htm" rel="noopener noreferrer">Venture</a></li>
<li><a target="" href="https://www.baincapitalrealestate.com" rel="noopener noreferrer">Real Estate</a></li>
<li><a target="_blank" href="//www.baincapitaltechopportunities.com" rel="noopener noreferrer">Tech Opportunities</a></li>
<li><a target="" href="https://www.baincapitallifesciences.com" rel="noopener noreferrer">Life Sciences</a></li>
<li><a target="_blank" href="//baincapitalpublicequity.com/" rel="noopener noreferrer">Public Equity</a></li>
<li><a target="_blank" href="//www.baincapitalpartnershipstrategies.com" rel="noopener noreferrer">Partnership Strategies</a></li>
<li><a target="_blank" href="https://www.baincapitalinsurance.com/" rel="noopener noreferrer">Insurance</a></li>
<li><a target="_blank" href="//baincapitaldoubleimpact.com" rel="noopener noreferrer">Double Impact</a></li>
<li><a target="_blank" href="../businesses/crypto.html" rel="noopener noreferrer">Crypto</a></li>
</ul>
</li>
<li><a class="hvr-underline-from-center " href="../people-19.html">
People </a>
</li>
<li><a class="hvr-underline-from-center " href="///www.baincapital.com/esgandimpact/">
ESG & Impact </a>
</li>
<li><a class="hvr-underline-from-center active " href="../news.html">
Newsroom </a>
</li>
</ul>
</div>

</div>
</div>
</div>
</nav>
</div>
</div>
</div>
</header>

<div class="modal fade" id="moreLinksFooterModal" tabindex="-1">
<div class="modal-dialog" role="document">
<div class="modal-content">
<div class="">
<button type="button" class="btn close-btn" data-dismiss="modal"><span class="glyphicon glyphicon-remove"></span></button>
<div class="moreLinksFooterWrap">
<div class="container-fluid">
<div class="row">
<div class="col-md-7 col-sm-12 col-xs-12 footerPadd0">
<div class="row">
<section class="header-section-left col-md-15 col-sm-12 col-xs-12">
<h3><a href="../about-us.html" target="" rel="noopener noreferrer">About Us</a></h3>
<button class="accordion"></button>
<ul class="panel">
<li><a href="../about-us.html#aboutBC">About Bain Capital</a></li>
<li><a href="../about-us.html#ourValues">Our Values</a></li>
<li><a href="../about-us.html#timeline">Our History</a></li>
<li><a href="../about-us.html#countNumber">By the Numbers</a></li>
</ul>
</section>
<section class="header-section-left col-md-15 col-sm-12 col-xs-12">
<h3 class=""><a href="javascript:void(0);">Local Sites</a></h3>
<button class="accordion"></button>
<ul class="panel">
<li>
<a href="https://www.baincapital.co.jp/">Japan - 日本</a>
</li>
</ul>
</section>
<section class="header-section-left col-md-15 col-sm-12 col-xs-12">
<h3><a href="../businesses.html">Businesses</a></h3>
<button class="accordion"></button>
<ul class="panel">
<li><a href="https://baincapitalprivateequity.com/" target="_blank" rel="noopener noreferrer">Private Equity</a></li>
<li><a href="https://www.baincapitalcredit.com/" target="_blank" rel="noopener noreferrer">Credit</a></li>
<li><a href="//baincapitalspecialsituations.com/">Special Situations</a></li>
<li><a href="../businesses/ventures/index.htm" target="_blank" rel="noopener noreferrer">Venture</a></li>
<li><a href="https://www.baincapitalrealestate.com" target="" rel="noopener noreferrer">Real Estate</a></li>
<li><a href="//baincapitaltechopportunities.com" target="_blank" rel="noopener noreferrer">Tech Opportunities</a></li>
<li><a href="https://www.baincapitallifesciences.com" target="" rel="noopener noreferrer">Life Sciences</a></li>
<li><a href="https://www.baincapitalpublicequity.com/" target="_blank" rel="noopener noreferrer">Public Equity</a></li>
<li><a href="//www.baincapitalpartnershipstrategies.com" target="_blank" rel="noopener noreferrer">Partnership Strategies</a></li>
<li><a href="https://www.baincapitalinsurance.com/" target="_blank" rel="noopener noreferrer">Insurance</a></li>
<li><a href="https://baincapitaldoubleimpact.com/" target="_blank" rel="noopener noreferrer">Double Impact</a></li>
<li><a href="../businesses/crypto.html" target="_blank" rel="noopener noreferrer">Crypto</a></li>
</ul>
</section>
<section class="header-section-left col-md-15 col-sm-12 col-xs-12">
<h3><a href="../people-19.html">People</a></h3>
<button class="accordion"></button>
<ul class="panel">
<li><a href="../people-19.html">Businesses</a></li>
<li><a href="../people-20.html?dept=38">Corporate</a></li>
</ul>
</section>
<section class="header-section-left col-md-15 col-sm-12 col-xs-12">
<h3><a href="../esgandimpact/index.htm">ESG & Impact</a></h3>
</section>
<section class="header-section-left col-md-15 col-sm-12 col-xs-12">
<h3><a href="../news.html">Newsroom</a></h3>
</section>
</div>
</div>
<div class="col-xs-12  col-sm-12 col-md-5 fullPara footerPadd0">
<p><strong>Bain Capital, LP</strong> is one of the world’s leading private investment firms with approximately $185 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact. </p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="modal fade investorPopUp" id="investorPopup" tabindex="-1" role="dialog" aria-labelledby="investorPopup">
<div class="modal-dialog" role="document">
<div class="modal-content">
<div class="modal-body">
<button type="button" class="btn close-btn" data-dismiss="modal"><i class="glyphicon glyphicon-remove"></i></button>
<div id="investorLoginMobile">
<div class="container-fluid">
<div class="row">
<div class="col-md-7">
<div class="col-md-6">
<p><strong class="paddB5">Bain Capital Investor Portal</strong> Please log in to access your account information. If you have any questions regarding your account, please contact <a href="mailto:ir@baincapital.com">ir@baincapital.com</a>.</p>
</div>
<div class="col-md-6">
<div class="signinOption">
<h4>Sign on to your account</h4>
<div class="btn-group">
<button type="button" class="btn btn-default dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
Select an account <span class="caret"></span>
</button>
<ul class="dropdown-menu">
<li><a href="https://services.intralinks.com/branding/4136419019/?clientID=4136419019" target="_blank" rel="nofollow noopener noreferrer">Private Equity</a></li>
<li><a href="https://services.intralinks.com/branding/3096257632/?clientID=3096257632" target="_blank" rel="nofollow noopener noreferrer">Credit</a></li>
<li><a href="https://services.intralinks.com/branding/4032613659/?clientID=4032613659" target="_blank" rel="nofollow noopener noreferrer">Public Equity</a></li>
<li><a href="https://services.intralinks.com/branding/8925604850/?clientID=8925604850" target="_blank" rel="nofollow noopener noreferrer">Ventures</a></li>
<li><a href="https://services.intralinks.com/branding/6382588619/?clientID=6382588619" target="_blank" rel="nofollow noopener noreferrer">Real Estate</a></li>
<li><a href="https://services.intralinks.com/branding/2968698844/?clientID=2968698844" target="_blank" rel="nofollow noopener noreferrer">Double Impact</a></li>
<li><a href="https://services.intralinks.com/branding/7947916997/?clientID=7947916997" target="_blank" rel="nofollow noopener noreferrer">Life Sciences</a></li>
<li><a href="https://services.intralinks.com/branding/9037940544/?clientID=9037940544" target="_blank" rel="nofollow noopener noreferrer">Partnership Strategies</a></li>
</ul>
</div>
</div>
</div>
</div>
<div class="col-md-5">
<div class="col-md-6">


<strong>Questions?</strong><br>
Call Us: <a href="https://intralinks.custhelp.com/app/answers/detail_clear/a_id/4034" target="_blank" rel="nofollow noopener noreferrer">24 x 7 Global Phone Support</a><br>
Email Us: <a href="mailto:support@intralinks.com">support@intralinks.com</a><br>

<a style="display: block; margin-top: 1em;" href="https://baincapital.com/people?dept=39">Meet the Bain Capital Investor Relations team</a>
</div>
</div> </div>
</div> </div>
</div>
</div>
</div>
</div>



<script>
	var banner_text_color = '';
	var banner_title = "";
	var banner_mbl_text_color = '';
	var content_type = '';
	var banner_secondary_title = JSON.stringify(null);
</script>
<div class="main-block full-width-main">

<div class="full-width posR">
<div class="slant" style="background: #CECDC9;">

<style type="text/css">
                    .slant-banner{
						background-image: url('../sites/all/themes/baincapital/assets/images/top-slider/grey-slider-1.jpg');
													background-size: 120% auto;
												
													background-position: center 220px;
												
					}
                    @media(min-width:768px) and (max-width:990px) {
                         .slant-banner{
                        							background-size: 140% auto; 
												
													background-position: center 185px; 
												
						}
                    }
                    @media(max-width:767px){
                      .slant-banner{
						background-image: url('../sites/all/themes/baincapital/assets/images/top-slider/grey-slider-1.jpg');
													background-size:170% auto;
													
							background-position:center 55px;
												}
                    }
                </style>
<div class="slant-banner"></div>
<div class="container-fluid slantStraight">
<article class="captionFixed hidden-xs " id="caption">

</article>
</div>
</div>
<div class="citizenResponse citizenResponseDetail newsroomDetail">
<div class="container-fluid">
<div class="row">
<div class="col-xs-12 col-sm-12 col-md-10 slider-caption dcaption dcaptions">
<div class="dtitle nstitle">
<h1 class="largeTitleResponse">Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding</h1>
<span class="date">July 12, 2022</span>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="container-fluid">
<article class="captionFixed  visible-xs " id="captionMobile">

</article>

<div class="slider-content visible-xs">
<section class="row">
<div class="col-md-6 col-sm-5 col-xs-12"></div>
<div class="col-md-6 col-sm-7 col-xs-12">
</div>
</section>
</div>
<div class="slider-content hidden-xs">
<section class="row">
<div class="col-md-6 col-sm-5 col-xs-12"></div>
<div class="col-md-6 col-sm-7 col-xs-12">
</div>
</section>
</div>
</div>
<style>
		.captionFixed.with-subtext .slider-subtext {
			position: relative;
			max-width: 80%;
			margin-top: 40px;
			font-size: 38px;
			line-height: 1.15;
			padding-left: 80px;
		}
		.captionFixed.with-subtext .slider-subtext img,
		.captionFixed.with-subtext .slider-subtext svg {
			max-width: 65px;
			position: absolute;
			top: 50%;
			left: 0;
			transform: translateY(-50%);
		}
		@media (min-width: 1400px) {
			.captionFixed.with-subtext {
			width: 960px;
			}
		}
		@media (max-width: 1399px) and (min-width: 1199px) {
			body .captionFixed.with-subtext {
			width: 840px;
			}
		}
		@media (max-width: 1199px) and (min-width: 992px) {
			.captionFixed.with-subtext {
			width: 760px;
			}
			.captionFixed.with-subtext .slider-subtext {
			font-size: 34px;
			margin-top: 30px;
			margin-bottom: 15px;
			}
		}
		@media (max-width: 991px) and (min-width: 768px) {
			.captionFixed.with-subtext {
			width: 600px;
			margin-bottom: 20px;
			}
			.captionFixed.with-subtext .slider-subtext {
			font-size: 25px;
			margin-top: 25px;
			padding-left: 65px;
			}
			.captionFixed.with-subtext .slider-subtext img,
			.captionFixed.with-subtext .slider-subtext svg {
			max-width: 50px;
			}
		}
		@media (max-width: 767px) {
			.slider-caption h2,
			.slider-caption h1 {
			font-size: 38px;
			}
			.captionFixed.with-subtext .slider-subtext {
			margin-top: 20px;
			margin-bottom: 30px;
			font-size: 26px;
			padding-left: 65px;
			}
			.captionFixed.with-subtext .slider-subtext img,
			.captionFixed.with-subtext .slider-subtext svg {
			max-width: 50px;
			}
			.captionFixed.with-subtext .slider-subtext svg {
			stroke: #000000 !important;
			}
			.captionFixed.with-subtext .slider-subtext a {
			color: #000000 !important;
			}
		}
		@media (max-width: 479px) {
			.slider-caption h2,
			.slider-caption h1 {
			font-size: 28px;
			}
			.captionFixed.with-subtext .slider-subtext img,
			.captionFixed.with-subtext .slider-subtext svg {
			max-width: 42px;
			}
			.captionFixed.with-subtext .slider-subtext {
			font-size: 21px;
			padding-left: 55px;
			}
		}
		@media (max-width: 380px) {
			.slider-caption h2,
			.slider-caption h1 {
			font-size: 28px;
			}
			.captionFixed.with-subtext .slider-subtext {
			font-size: 20px;
			}
		}
		</style><script type="text/javascript">
jQuery('document').ready(function($){
   	$( ".SearchFrm" ).submit(function(){
		if($('input[type="text"]').val().length == 0){
			return false;	
		}
	});
	$( ".mobileSearch" ).submit(function(){
		if($('.mobileSearch input[type="text"]').val().length == 0){
			return false;	
		}
	});		
});
</script>

<div class="allContent ourCommunityDetailWrapMain">
<div class="posR">
<div class="container-fluid">
<div class="allContentWrap1 newsContentWrap">
<div class="btnSet">
<button class="btn text-uppercase hvr-sweep-to-top valueBtn btn-block hidden-md hidden-lg" type="button" data-toggle="collapse" data-target="#valueCollapse">Media Contacts<i class="glyphicon glyphicon-triangle-bottom"></i> </button>
</div>
<div class="row">
<div class="col-xs-12 col-sm-12 col-md-3 sidestickParentW">
<div class="sideStick" data-gumshoe-header="">
<div class="sharePage hidden-xs hidden-sm   stickProfileImage" data-gumshoe="">
<h4>Share this page</h4>
<ul>
<li>
<a class="mailIco addthis_button_email" href="#" title="" data-placement="top" data-toggle="tooltip" target="_blank" data-original-title="Share on Mail"><i class="fa fa-envelope-o"></i></a>
</li>
<li>
<a class="linkIco addthis_button_linkedin" href="#" title="" data-placement="top" data-toggle="tooltip" target="_blank" data-original-title="Share on LinkedIN"><i class="fa fa-linkedin"></i></a>
</li>
<li>
<a class="twtIco addthis_button_twitter" href="#" title="" data-placement="top" data-toggle="tooltip" target="_blank" data-original-title="Share on Twitter"><i class="fa fa-twitter"></i></a>
</li>
<li>
<a class="fbIco addthis_button_facebook" href="#" title="" data-placement="top" data-toggle="tooltip" target="_blank" data-original-title="Share on Facebook"><i class="fa fa-facebook-f"></i></a>
</li>
</ul>
</div>
<div class="sharePage mediaContact">
<h3 class="pageTitle pageTitleNs">Media Contacts</h3>
<div class="clist">
<ul>
<li>
<h5>
For Areteia Therapeutics<br> Tamsin Berry <br>
+44-7779-010731
</h5>
<a href="mailto:Tamsin.Berry@areteiatx.com">
Tamsin.Berry@areteiatx.com </a>
</li>
<li>
<h5>
For Bain Capital Life Sciences <br> Scott Lessne
Stanton <br>
(646) 502-3569
</h5>
<a href="mailto:slessne@stantonprm.com ">
slessne@stantonprm.com </a>
</li>
</ul> </div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="allcontentBgBain allcontentBgBainNewsDetail">
<div class="allContentWrapper">
<div class="responsibleSpaceMinus newsDetailPageSpacing">
<section class="ourCommunityDetailWrap">
<div class="posR full-width community_partnerDetailBG">
<div class="rightContent">
<div class="container-fluid">
<div class="border-sidebar visible-sm visible-xs">
<div class="sharePage border-top">
<h4>Share this page</h4>
<ul>
<li>
<a class="mailIco addthis_button_email" href="#" title="" data-placement="top" data-toggle="tooltip" target="_blank" data-original-title="Share on Mail"><i class="fa fa-envelope-o"></i></a>
</li>
<li>
<a class="linkIco addthis_button_linkedin" href="#" title="" data-placement="top" data-toggle="tooltip" target="_blank" data-original-title="Share on LinkedIN"><i class="fa fa-linkedin"></i></a>
</li>
<li>
<a class="twtIco addthis_button_twitter" href="#" title="" data-placement="top" data-toggle="tooltip" target="_blank" data-original-title="Share on Twitter"><i class="fa fa-twitter"></i></a>
</li>
<li>
<a class="fbIco addthis_button_facebook" href="#" title="" data-placement="top" data-toggle="tooltip" target="_blank" data-original-title="Share on Facebook"><i class="fa fa-facebook-f"></i></a>
</li>
</ul>
</div>
</div>
<div class="row">
<div class="col-md-7 col-sm-12 col-md-offset-3">
<div class="setCont scrollCommom">
<div class="detail-image">
<img src="../sites/default/files/news/Areteia_1.png" alt="Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding">
</div>
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center" style="margin-right:45.0pt; text-align:center; margin:0in 0in 0in 0.5in"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><i><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">Areteia will initiate Phase 3 trials of lead candidate, dexpramipexole, a potential first-in-class oral drug for eosinophilic asthma, in late 2022</span></span></span></i></span></span></span><br> </p><p style="margin-right:45.0pt; text-align:justify; margin:0in 0in 0in 0.5in"> </p><p align="center" style="margin-top:12.0pt; margin-right:45.0pt; margin-bottom:0in; margin-left:.5in; text-align:center; margin:0in 0in 0in 0.5in"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><i><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">Investors led by Bain Capital Life Sciences</span></span></span></i><i> </i><i><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">to invest up to $350 million in Series A financing</span></span></span></i></span></span></span><br> </p><p align="center" style="margin-right:45.0pt; text-align:center; margin:0in 0in 8pt 0.5in"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><i><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">Jorge Bartolome joins Areteia as CEO, bringing industry leadership experience in respiratory therapeutics</span></span></span></i></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">PITTSBURGH, PA &amp; SHORT HILLS, NJ – July 12, 2022 –</span></span></span></b><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black"> Areteia Therapeutics, Inc. (“Areteia”) today announces its launch as a clinical-stage biopharmaceutical company focused on putting asthma patients in better control of their disease – and back in control of their lives – with the first potential oral therapy for eosinophilic asthma. Areteia’s lead drug candidate is dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. </span></span></span></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">Areteia was created by Population Health Partners and Knopp Biosciences. A syndicate of leading life sciences and strategic investors led by Bain Capital Life Sciences with participation from Access Biotechnology, GV, ARCH Venture Partners, Saturn Partners, Sanofi, Maverick Capital, and Population Health Partners, has committed to invest up to $350 million in Series A financing to establish Areteia and advance dexpramipexole through Phase 3 clinical trials, secure commercial supply, and pursue potential next-generation medicines. Knopp, which previously owned and conducted early-stage development of dexpramipexole, contributed the lead investigational drug and related assets to Areteia in connection with the transaction.  </span></span></span></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">Jorge Bartolome, a seasoned biopharmaceutical executive with more than 25 years of industry experience, has been appointed Areteia’s Chief Executive Officer. Previously, Mr. Bartolome served as the President of Canada for the Janssen Pharmaceutical Companies of Johnson &amp; Johnson. Before that, he served as Senior Vice President of the US Respiratory Business Unit of GlaxoSmithKline plc, where he led a period of rapid expansion, including the commercialization and launch of an industry leading portfolio of asthma therapeutics. </span></span></span></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">“Asthma is a common disease with a high unmet need and significant impact on the health and lives of millions of patients around the world,” said Mr. Bartolome. He added, “I am excited to partner with an expert team of drug developers to advance the first-ever oral treatment for eosinophilic asthma on behalf of these patients.” </span></span></span></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">“The Founders and Board of Knopp Biosciences are delighted to see dexpramipexole move forward into Phase 3 development with a significant funding commitment led by Bain Capital Life Sciences, and in the experienced hands at Areteia and Population Health Partners,” said Michael Bozik, M.D., President, Biohaven Labs, and the former President and Chief Executive Officer of Knopp.</span></span></span></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">“Population Health Partners was founded to invest in innovation to tackle the biggest burdens of human disease – and asthma is high on our list of priorities,” said Clive Meanwell, M.D., Chairman and Managing Partner of Population Health Partners. “The world-class product development evidence generation team in our Validae Health unit will partner with Areteia to execute the development program and undertake lifecycle management with the highest levels of efficiency and quality.”</span></span></span></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">“We are excited to collaborate with a strong founding team that brings deep clinical and commercial experience focused on long-term fundamental drug development in areas of great unmet need, such as patients suffering from severe respiratory diseases like eosinophilic asthma,” stated Adam Koppel, M.D., PhD, Managing Director of Bain Capital Life Sciences. “We look forward to providing the resources and company creation support needed to enable Areteia to thoughtfully advance this innovative lead therapy while supporting the Company’s patient-centric mission.”</span></span></span></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><span lang="EN-GB" style="font-size:12.0pt" xml:lang="EN-GB"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">“It has become clear that lowering the blood eosinophil count results in important clinical benefits in patients with severe eosinophilic asthma</span></span></span><span lang="EN-GB" style="font-size:12.0pt" xml:lang="EN-GB"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">,” added Ian Pavord, Professor of Respiratory Medicine at the University of Oxford. “</span></span></span><span lang="EN-GB" style="font-size:12.0pt" xml:lang="EN-GB"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">Until now, we have only been able to do this with oral steroids or injected biologic treatments. The prospect of an orally active eosinophil lowering drug which is free of the adverse effects of oral steroids is compelling and the research community is going to join in this important quest enthusiastically.”</span></span></span></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif">Cowen acted as exclusive placement agent for the Series A financing.</span></span></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">About Eosinophilic Asthma</span></span></span></b></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">Asthma disrupts the lives of more than a quarter of a billion people worldwide. More than half of asthma patients have eosinophilic asthma, which is driven by an oversupply of eosinophils, a type of white blood cell, in blood and tissue. By inhibiting the maturation of eosinophils, oral dexpramipexole acts in a way similar to injectable anti-IL-5 biologic therapies. </span></span></span><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif">The asthma biologic market is experiencing growth of 10% per year and is valued at around $8 billion, with IL-5 biologic therapies representing approximately $3 billion of that figure. <span style="color:black">If approved as a first-to-market oral, dexpramipexole could provide a compelling alternative to injectable biologics, and could potentially be used earlier in the asthma treatment paradigm to prevent progression of disease.</span></span></span></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">About Dexpramipexole</span></span></span></b></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">Dexpramipexole is an oral small molecule in phase 3 development for eosinophilic asthma. Dexpramipexole inhibits the maturation and release of eosinophils in bone marrow, based on evidence from cell cultures and human biopsies, thereby lowering peripheral blood eosinophil levels. Most recently in a Phase 2 study in patients with moderate-to-severe eosinophilic asthma, treatment with dexpramipexole resulted in a significant, dose-dependent reduction in blood absolute eosinophil count at all doses tested (daily dexpramipexole doses of 37.5 mg, 75 mg, or 150 mg twice daily) compared to placebo. Dexpramipexole was well tolerated in the trial, with adverse events balanced across treatment and placebo groups, no serious adverse events, and no adverse events leading to discontinuation.</span></span></span></span></span></span></p><p style="margin-bottom:6.0pt; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:28.5pt"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">About Areteia Therapeutics</span></span></span></b></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">Areteia Therapeutics (areteiatx.com) is a clinical stage biotechnology company committed to putting asthma patients in better control of their disease and lives by developing the first potential oral drug for eosinophilic asthma. Areteia will conduct late-stage development including Phase 3 clinical trials of dexpramipexole in partnership with Population Health Partners’ development unit, Validae Health. Areteia will be led by Chief Executive Officer, Jorge Bartolome, with a Board of Directors including Michael Bozik, M.D., President, Biohaven Labs, and the former President and Chief Executive Officer of Knopp; Adam Koppel, M.D., PH.D., Managing Director of Bain Capital Life Sciences; Ian Read, Partner at Population Health Partners and the former Chairman and Chief Executive Officer of Pfizer; and Paul Berns, Managing Director at Arch Ventures. </span></span></span></span></span></span></p><p style="margin-bottom:6.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">About Knopp Biosciences LLC</span></span></span></b></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">Knopp Biosciences is a privately held drug biotechnology company with a 20-year record of drug discovery and development in challenging immunological and neurological diseases. Knopp’s clinical-stage oral small molecule, dexpramipexole, is being developed by Areteia Therapeutics, a subsidiary of Knopp, and is entering Phase 3 development in eosinophilic asthma. Knopp’s preclinical Kv7 platform, directed to innovative, small-molecule treatments for epilepsy and other hyperexcitability disorders, has been acquired and is being advanced by Biohaven Pharmaceuticals. Please visit </span></span></span><a href="http://www.knoppbio.com." style="color:blue; text-decoration:underline"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black"><span style="text-decoration:none"><span style="text-underline:none">www.knoppbio.com.</span></span></span></span></span></a></span></span></span></p><p style="margin-bottom:6.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">About Population Health Partners, L.P.</span></span></span></b></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">Population Health Partners, L.P. is a private equity firm committed to building great companies around important late-stage therapeutics, and generating superior returns for our investing partners by solving the health and economic challenges presented by prevalent diseases. Population Health Partners employs a</span></span></span><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"> team <span style="color:black">of expert drug developers in a unit called Validae Health, focused on generating late-stage clinical evidence at industry-leading levels of efficiency. While at The Medicines Company, leaders from Population Health Partners secured eight drug approvals involving 21 clinical trials and 91,000 randomized patients and were ranked #1 in the CNBC RQ 50 for biopharmaceutical R&amp;D productivity. Please visit </span></span></span><a href="http://www.populationhp.com" style="color:blue; text-decoration:underline"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">www.populationhp.com</span></span></span></a><span class="MsoHyperlink" style="color:blue"><span style="text-decoration:underline"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif"><span style="color:black">.</span></span></span></span></span></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif">About Bain Capital Life Sciences</span></span></b></span></span></span></p><p style="margin-bottom:12.0pt; text-align:justify; margin:0in 0in 8pt"><span style="font-size:11pt"><span style="line-height:18.75pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif">Bain Capital Life Sciences (</span></span><a href="http://www.baincapitallifesciences.com" style="color:blue; text-decoration:underline"><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif">www.baincapitallifesciences.com</span></span></a><span style="font-size:12.0pt"><span style="font-family:&quot;Arial&quot;,sans-serif">) invests in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe, with a focus on companies that both drive medical innovation across the value chain and enable that innovation to improve the lives of patients with unmet medical needs. The differentiated skillset of Bain Capital Life Sciences team enables it to deliver targeted capital land value-added strategic support to companies around critical phases of growth and inflections in value. Since 1984, Bain Capital has employed a strategic and analytical approach to identify attractive investment opportunities and partner with management teams to transform and improve their businesses. During this time, Bain Capital has developed global reach, deep expertise, and a proven track record in the life sciences industries across private equity, public equity, credit, venture capital, and real estate.</span></span></span></span></span></p></div></div></div> </div>
</div>
</div>
</div>
</div>
</div>
</section>
</div>
</div>
</div>
</div>
<div class="communitypartWrap latest-cpwrap nsdetailLatest">
<div class="container-fluid">
<h2>Related Articles</h2>
<div class="ourBusinessGrid">
<div class="row">
<div class="col-md-4 col-sm-12">
<div class="cpwrap-img">
<a href="aiolos-bio-launches-245-million-series-investment-advance-development-novel-phase-2-ready-tslp.html">
<img alt=" Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody " src="../sites/all/themes/baincapital/assets/images/newsroom/newsroom-detail2.jpg">
</a>
</div>
<div class="cpwrap-detail">
<div class="communityPartDt">
<small class="newsCreadit">10.25.23 </small>
<h3><a href="aiolos-bio-launches-245-million-series-investment-advance-development-novel-phase-2-ready-tslp.html" class="purAtitle"> Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody </a></h3>
</div>
</div>
</div>
<div class="col-md-4 col-sm-12">
<div class="cpwrap-img">
<a href="adarx-pharmaceuticals-leader-next-generation-rna-therapeutics-announces-oversubscribed-200.html">
<img alt="ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing" src="../sites/default/files/news/CQMED-Projects-RNAs.jpg">
</a>
</div>
<div class="cpwrap-detail">
<div class="communityPartDt">
<small class="newsCreadit">8.9.23 </small>
<h3><a href="adarx-pharmaceuticals-leader-next-generation-rna-therapeutics-announces-oversubscribed-200.html" class="purAtitle">ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing</a></h3>
</div>
</div>
</div>
<div class="col-md-4 col-sm-12">
<div class="cpwrap-img">
<a href="jnana-therapeutics-raises-107-million-advance-lead-pku-program-and-progress-therapeutics.html">
<img alt="Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform" src="../sites/default/files/news/145__Jnana-2022.png">
</a>
</div>
<div class="cpwrap-detail">
<div class="communityPartDt">
<small class="newsCreadit">11.15.22 </small>
<h3><a href="jnana-therapeutics-raises-107-million-advance-lead-pku-program-and-progress-therapeutics.html" class="purAtitle">Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform</a></h3>
</div>
</div>
</div>
</div>
</div>
</div>
</div>

<section class="footerSpace"></section>

<footer>
<div class="container-fluid">
<div class="sharePage">
<ul>
<li>
<a class="linkIco at300b " href="https://www.linkedin.com/company/bain-capital" title="LinkedIn" data-placement="top" data-toggle="tooltip" target="_blank" rel="nofollow" data-original-title="share on LinkedIn"><span class="fa fa-linkedin"></span></a>
</li>
<li>
<a class="twtIco at300b " href="https://twitter.com/baincapital?lang=en" title="Twitter" data-placement="top" data-toggle="tooltip" target="_blank" rel="nofollow" data-original-title="share on Twitter"><span class="fa fa-twitter"></span></a>
</li>
</ul>
</div>
<a href="../index.htm">
<img class="pull-right footer-logo wow slideInDown" data-wow-delay="0.5s" src="../sites/all/themes/baincapital/assets/images/baincapital-outline-blue-Logo-1.svg" alt="Baincapital" height="37">
</a>
<hr class="clearb">
<div class="row">
<div class="col-lg-5 col-md-4 col-sm-12 col-xs-12 fullPara">
<p><strong>Bain Capital, LP</strong> is one of the world’s leading private investment firms with approximately $185 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact. </p>
</div>
<div class="col-lg-7 col-md-8 col-sm-12 col-xs-12 footerPadd0">
<div class="row row-links">
<section class="footer-section-left col-md-15 col-sm-15">
<h3><a target="" href="../about-us.html" rel="noopener noreferrer">About Us</a></h3>
<ul class="hidden-xs">
<li><a href="../about-us.html#aboutBC">About Bain Capital</a></li>
<li><a href="../about-us.html#ourValues">Our Values</a></li>
<li><a href="../about-us.html#timeline">Our History</a></li>
<li><a href="../about-us.html#countNumber">By the Numbers</a></li>
</ul>
</section>
<section class="footer-section-right col-md-15 col-sm-15">
<h3><a href="../businesses.html">Businesses</a></h3>
<ul class="hidden-xs">
<li><a target="_blank" href="https://baincapitalprivateequity.com/" rel="noopener noreferrer">Private Equity</a></li>
<li><a target="_blank" href="https://www.baincapitalcredit.com/" rel="noopener noreferrer">Credit</a></li>
<li><a href="//baincapitalspecialsituations.com/">Special Situations</a></li>
<li><a target="_blank" href="../businesses/ventures/index.htm" rel="noopener noreferrer">Venture</a></li>
<li><a target="" href="https://www.baincapitalrealestate.com" rel="noopener noreferrer">Real Estate</a></li>
<li><a target="_blank" href="//baincapitaltechopportunities.com" rel="noopener noreferrer">Tech Opportunities</a></li>
<li><a target="" href="https://www.baincapitallifesciences.com" rel="noopener noreferrer">Life Sciences</a></li>
<li><a target="_blank" href="https://www.baincapitalpublicequity.com/" rel="noopener noreferrer">Public Equity</a></li>
<li><a target="_blank" href="//www.baincapitalpartnershipstrategies.com" rel="noopener noreferrer">Partnership Strategies</a></li>
<li><a target="_blank" href="https://www.baincapitalinsurance.com/" rel="noopener noreferrer">Insurance</a></li>
<li><a target="_blank" href="https://baincapitaldoubleimpact.com/" rel="noopener noreferrer">Double Impact</a></li>
<li><a target="_blank" href="../businesses/crypto.html" rel="noopener noreferrer">Crypto</a></li>
</ul>
</section>
<section class="footer-section-left col-md-15 col-sm-15">
<h3><a href="../people-19.html">People</a></h3>
<ul class="hidden-xs">
<li><a href="../people-19.html">Businesses</a></li>
<li><a href="../people-20.html?dept=38">Corporate</a></li>
</ul>
</section>
<section class="footer-section-right col-md-15 col-sm-15">
<h3><a href="../esgandimpact/index.htm">ESG & Impact</a></h3>
<ul class="hidden-xs">
</ul>
</section>
<section class="footer-section-left col-md-15 col-sm-15">
<h3><a href="../news.html">Newsroom</a></h3>
</section>
</div>
</div>
</div>
<div class="copyright">
<div class="row">
<div class="col-md-12">
<p class="bottomDisclaimer">The trademarks and logos above are used for reference purposes only, and are the property of their respective owners.<br>
No endorsement of Bain Capital is intended by the use of such trademarks.</p>
<p> © 2012-2024 Bain Capital, LP. The Bain Capital square symbol is a trademark of Bain Capital, LP. All Rights Reserved.<br><a href="../privacy-policy.html">Privacy Policy</a><a href="../terms-use.html">Terms of Use</a><a href="../regulatory-disclosures.html">Regulatory Disclosures</a><a href="../fraud-and-cybersecurity-warning.html">Fraud and Cybersecurity Warning</a>

<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WLFBKSQ4" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
</p>
</div>
</div>
</div>
</div>
</footer>
</div>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
window.eu_cookie_compliance_cookie_name = "";
//--><!]]>
</script>
<script type="text/javascript" defer="defer" src="../sites/all/modules/eu_cookie_compliance/js/eu_cookie_compliance.min-1.js?sghuir"></script>
<script type="text/javascript" src="../sites/all/themes/baincapital/assets/js/all-jquery-1.js?sghuir"></script>
<script type="text/javascript" src="../sites/all/themes/baincapital/assets/js/bootstrap.min-1.js?sghuir"></script>
<script type="text/javascript" src="../sites/all/themes/baincapital/assets/js/owl.carousel-1.js?sghuir"></script>
<script type="text/javascript" src="../sites/all/themes/baincapital/assets/js/tweet-1.js?sghuir"></script>
<script type="text/javascript" src="../sites/all/themes/baincapital/assets/js/jquery.waypoints.min-1.js?sghuir"></script>
<script type="text/javascript" src="../sites/all/themes/baincapital/assets/js/scrollfix-1.js?sghuir"></script>
<script type="text/javascript" src="../sites/all/themes/baincapital/assets/js/news_detail.js?sghuir"></script>
<script type="text/javascript" src="../sites/all/themes/baincapital/assets/js/mainjq-1.js?sghuir"></script>
<script type="text/javascript" src="../sites/all/themes/baincapital/assets/js/bc-private-equity-1.js?sghuir"></script>
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'8a2fa17bf92247e5',t:'MTcyMDk0MDM3Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body>
</html>
